360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Phase III

Type: Keyphrase

Name: Phase III

First reported 19 hours ago - Updated 25 mins ago - 4 reports

Bristol-Myers Squibb Company

Bristol-Myers Shares Jump as Analyst Hails New Cancer Treatment Drug

Relateret indhold 18:44 - MARKET SNAPSHOT: U.S. Stocks Hold Gains After Bernanke .. 18:13 - EUROPE MARKETS: Europe Stocks Climb After Bernanke Comm.. 14:33 - EUROPE MARKETS: Europe Stocks Slide Ahead Of Bernanke C.. By Russ Britt Shares of Bristol-Myers ... [Published EuroInvestor - 14 hours ago]

Entities: Bristol-Myers Squibb Company, Cancer, Stocks

First reported 13 hours ago - Updated 5 hours ago - 2 reports

Rockwell Steadies Itself For A Phase III Run-Up

Home » Blogs » Rockwell Medical (RMTI) is a bio-pharmaceutical company that's focused on addressing end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism ... [Published BioPortfolio - 5 hours ago]

Entities: Phase III, Iron, Dialysis

First reported 23 hours ago - Updated 6 hours ago - 2 reports

Alzheimer’s drug trial coincides with UK’s Dementia Awareness week

TauRx Therapeutics has announced that the first of over 100 UK patients have enrolled in the global Phase III clinical trials of its experimental Alzheimer's drug LMTX.The news coincides with Dementia Awareness Week in the UK launched by the Alzheimer's ... [Published Pharmaceutical Technology - 15 hours ago]

Entities: Alzheimer's Disease, Dementia, TauRx Therapeutics Ltd

First reported May 22 2013 - Updated 9 hours ago - 2 reports

Lilly Halts Phase III Trial of Non-Hodgkin?s Lymphoma Drug

Home > Newsletters > Clinical Trials Advisor > Lilly Halts Phase III Trial of Non-Hodgkin’s Lymphoma Drug ... [Published FDA News - 9 hours ago]

Entities: Non-Hodgkin's Lymphoma, Phase III, Drugs

First reported 13 hours ago - Updated 9 hours ago - 2 reports

Positive Phase III Results With Simeprevir in Hepatitis Patients

NDA submitted for treatment of genotype 1 hepatitis C (May 21)Positive results have been reported from the global phase III PROMISE trial, which compared the investigational protease inhibitor simeprevir (TMC435; Janssen R&D Ireland), administered once ... [Published PT Community - 9 hours ago]

Entities: Simeprevir, Genotype, Patient

First reported May 21 2013 - Updated 15 hours ago - 3 reports

Boehringer Ingelheim GmbH

Phase III Success for Boehringer Ingelheim Asthma Drug

Boehringer Ingelheim said today its once-daily asthma drug tiotropium, delivered via Respimat® Soft Mist™ Inhaler, produced favorable Phase III results by increasing the time to first severe exacerbation, and time to first episode of asthma worsening ... [Published Genetic Engineering News - 15 hours ago]

Entities: Boehringer Ingelheim GmbH, Phase III, Patient

First reported 19 hours ago - Updated 16 hours ago - 2 reports

AMERICAN WATER WORKS COMPANY INC: American Water Receives Ten National Awards for Excellence in Water Quality

Three plants are among the first in the nation to receive a new 15-year certificationAmerican WaterWorks Company, Inc. (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company, is proud to announce the achievement of ten Directors ... [Published 4 Traders - 16 hours ago]

Entities: Water Treatment, Phase III, American Water Works Company Inc, Certification, Water Quality

First reported 20 hours ago - Updated 18 hours ago - 3 reports

Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials...

) - Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can be purchased for around 0.15/share allowing investors to build an incredible position in the company ... [Published BioMedReports - 18 hours ago]

Entities: Nuvilex Inc, Phase III, FDA Food & Drug Administration, Oncology, inoperable

First reported 22 hours ago - Updated 22 hours ago - 2 reports

OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting

BOTHELL, Wash.Despite the availability of drugs that improve survival in patients with cancer, treatment failure attributed to resistance continues to be a major problem in medical oncology.1,2,3,4 Across multiple tumor types, the majority of patients ... [Published Bio-Medicine - 22 hours ago]

Entities: OncoGenex Pharmaceuticals, Cancer, Phase III, Scott Cormack, OGX-427

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Pfizer pulls development of cancer drug

Inotuzumab ozogamicin fails to show survival benefit in late-stage trialPfizer has discontinued the development of cancer candidate inotuzumab ozogamicin in the haematological cancer non-Hodgkin lymphoma after it failed to show benefit in overall survival ... [Published PMLive - May 21 2013]

Entities: Pfizer Inc, Inotuzumab ozogamicin, antineoplastic, Cancer

First reported May 21 2013 - Updated May 21 2013 - 2 reports

AstraZeneca PLC Release: Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at

AstraZeneca (NYSE: AZN) today presented the results of two pivotal Phase III studies of naloxegol showing the 25 mg dose of the investigational drug met its primary and secondary endpoints for efficacy and showed a safety profile consistent with previous ... [Published BioSpace - May 21 2013]

Entities: naloxegol, Phase III, AstraZeneca PLC, Constipation

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Obayashi JV wins 14-building Doha complex

Msheireb Properties has awarded a QR2.5bn (438m) building contract to a consortium of Obayashi Corporation and HBK Contracting. The contract is for the penultimate stage, Phase 3, of its flagship project, Msheireb Downtown Doha. Phase 3 involves the construction ... [Published Construction Index - May 21 2013]

Entities: OBAYASHI Corporation, Doha (Qatar), Phase III, Construction

Quotes

The market authorisation granted for VESOMNI is for "treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia (BPH) in men who are not adequately responding to treatment with monotherapy" .1

ASTELLAS RECEIVES MARKETING AUTHORISATION FOR VESOMNITM FROM THE NETHERLANDS MEDICINES EVALUATION ... [Published Noodls - 1 hour ago]

...Randy Bateman, the Charles and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine, and trial Director. "These tests may provide valuable insights into the earliest mental changes in pre-symptomatic Alzheimer's disease. We are excited to move forward with this trial to determine whether it is possible to prevent or slow the onset of Alzheimer's in patients who are genetically destined to develop the disease."

Cogstate selected for pioneering Alzheimer's disease preventation trial [Published Noodls - 1 hour ago]

Aradigm president and CEO Igor Gonda said, "Grifols is a great fit for us with their global reach of respiratory physicians treating a number of conditions that could benefit from Pulmaquin." Latest News

Grifols, Aradigm sign licensing deal for inhaled ciprofloxacin formulations [Published Pharmaceutical Business Review - 2 hours ago]

"The contractor is gonna open up the new section of the bridge that they finished on the ocean side and the two lanes leading up to the bridge,” DPW Director Carl Dominguez explain. “Motorists will be driving in the meantime on concrete not asphalt the asphalt will come later when the project is almost done.”"

Phase I of Hagatna Bridge Project Completed, 8 Months Behind Schedule [Published Pacific News Center - 2 hours ago]

More Content

sort by: Date \| Relevance
Novo Nordisk Says Completes Hemophilia Drug Trial [Published AAPS Pharmceutica - 25 mins ago]
Sanofi Highlights Positive PhIII Study for Myel... [Published AAPS Pharmceutica - 25 mins ago]
Guest blog: Cell therapy approval and reimburse... [Published Terrapinn - 44 mins ago]
ImmuPharma funding provides "external validatio... [Published Proactive Investors USA - 50 mins ago]
ASTELLAS RECEIVES MARKETING AUTHORISATION FOR V... [Published Noodls - 1 hour ago]
Cogstate selected for pioneering Alzheimer's di... [Published Noodls - 1 hour ago]
WHO Publishes Draft On Revised Process Validati... [Published Pharmaceutical Online - 1 hour ago]
IsDB expected to provide some $10.1 mln loan fo... [Published Asia Plus - 1 hour ago]
Grifols, Aradigm sign licensing deal for inhale... [Published Pharmaceutical Business Review - 2 hours ago]
Phase I of Hagatna Bridge Project Completed, 8 ... [Published Pacific News Center - 2 hours ago]
Project to drain reservoirs gets under way [Published North Jersey.com - 2 hours ago]
REG-Max Property Group plc : Final Results [Published Reuters - 2 hours ago]
Biogen Idec Submits Application to FDA for Appr... [Published Individual.com - 3 hours ago]
Grifols, S.A. Inks Licensing Pact with Aradigm ... [Published Individual.com - 3 hours ago]
Cytokinetics' CEO Hosts the Annual Meeting of S... [Published Seeking Alpha - 4 hours ago]
Mood of pessimism in economy will be reversed s... [Published New Indian Express - 4 hours ago]
Nichi-Iko Japan President: Joint Infliximab Pha... [Published The Rose Sheet - 5 hours ago]
Rockwell Steadies Itself For A Phase III Run-Up [Published BioPortfolio - 5 hours ago]
Boston Scientific Announces Results from Promus... [Published BioMedReports - 6 hours ago]
Early Vitrectomy for DME: Does It Have a Role? [Published Retinal Physician - 6 hours ago]
New wonder pill ‘could halt dementia’ [Published Daily Express - 6 hours ago]
Hutama Karya eyes IDR... [Published Bisnis - 7 hours ago]
FDA Approval Sought for New MS Drug [Published The Guardian Express - 7 hours ago]
Conversation Phase 3: Panels offer big plans [Published Jewish News of Greater Phoenix - 8 hours ago]
FDA Recommends Running Phase 2b Trial of Repros... [Published Benzinga.com - 8 hours ago]
FDA Recommends Running Phase 2b Trial of Proell... [Published OSIX News - 9 hours ago]
Riociguat Shows Promise in Pulmonary HTN [Published MedPage Today - 9 hours ago]
Potential Alzheimer’s treatment to begin phase ... [Published Alzheimers Research - 9 hours ago]
ASCO13: What ‘Building Bridges’ Means for Oncology [Published Oncology Times - 9 hours ago]
Lilly Halts Phase III Trial of Non-Hodgkin?s Ly... [Published FDA News - 9 hours ago]

Blogs

sort by: Date \| Relevance
Four Signs That We're Back In Dangerous Bubble ... [Published Zero Hedge - 13 hours ago] Submitted by Chris Martenson of Peak Prosperity blog , As the global equity and bond markets grind ever higher, abundant signs exist that we are once again living through an asset bubble – or rather a whole series of bubbles in a variety of markets. ...
AVEO and Astellas to Present Tivozanib Clinical... [Published News from Kidney Cancer Association - 18 hours ago] AVEO Oncology and Astellas Pharma Inc. announced that additional data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) of investigational agent tivozanib in patients with advanced renal cell carcinoma (RCC) will be ...
US EQUITIES OPENING HEADLINES INCLUDING: Amarin... [Published Proactiveinvestors United Kingdom website - 19 hours ago] US equity futures point to a marginally higher open on Wall Street although have been trading in thin volumes throughout the day as market participants sit on the sidelines ahead of key risk events later in the session. Fed chairman Bernanke is due ...
First UK Patients Enrol in Phase 3 clinical tri... [Published Pharma-Mag - 23 hours ago] Clinical trials get under way in the UK with a second-generation tau aggregation inhibitor (TAI) aimed athalting the progression of Alzheimer’s. Coinciding with Dementia Awareness Week in the UK, TauRx Therapeutics Ltd announced that the first of ...
4 Healthcare Stock Stories For Tuesday Investme... [Published Wall St. Cheat Sheet - May 21 2013] Boston Scientific Corporation ( NYSE:BSX ): Closing price $9.23 Five-year data from the Asthma Intervention Research 2 clinical trial presented on Tuesday showed that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues ...

Audio/Video

sort by: Date \| Relevance
Marvel's Phase 3 Movie Plans [Published IGN Entertainment - YouTube - May 18 2013]
Star Wars Spin Offs, Marvel Phase 3 & Kick-Ass!... [Published IGN Entertainment - YouTube - Feb 07 2013]
Marvel's Phase 3 Movie Rumors [Published IGN Entertainment - YouTube - Feb 05 2013]
Marvel Phase 3 Movie Rumors & Smash Bros. Melee... [Published IGN Entertainment - YouTube - Feb 05 2013]

Press Releases

sort by: Date \| Relevance
American Water Receives Ten National Awards for... [Published EON: Enhanced Online News - 16 hours ago]
American Water Receives Ten National Awards for... [Published Business Wire - 16 hours ago]
American Water Receives Ten National Awards for... [Published EON Environment - 16 hours ago]
American Water Receives Ten National Awards for... [Published EON Energy - 16 hours ago]
American Water Receives Ten National Awards for... [Published Business Wire Environment News - 16 hours ago]